Michael J. Farrell - Jul 8, 2024 Form 4 Insider Report for RESMED INC (RMD)

Signature
Michael J. Farrell, Chief Executive Officer
Stock symbol
RMD
Transactions as of
Jul 8, 2024
Transactions value $
-$1,585,569
Form type
4
Date filed
7/10/2024, 12:04 PM
Previous filing
Jul 2, 2024
Next filing
Aug 9, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -14.7K -20% $0.00 58.7K Jul 8, 2024 ResMed Common Stock 14.7K $84.98 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $192.03 - $194.73. The price reported above reflects the weighted average sale price.
F3 Represents date options first became exercisable. Options vest 1/3 per year.